Amber Hall

Bachelor of Medicine and Bachelor of Science,  Toronto General - University Health Network 

Location: United States

Consulting Services

Pharma-CRO-Device Career Advice and Mentoring Data Science-Bioinformatics Research Consulting Case Consulting

Areas Of Interest

NADH Diaphorase Agonists, P2Y2 Purinoceptor Leukemia, Acute Lymphoid Apo Sertraline Blood Coagulation Factor X, Activated Evans Rats, Long Ligustrum lucidum Ramies Bone Mineral Density T Cell Factors Diplomonad Fungal Microbiotas United States Physician Payment Review Commission Vasoxyl Methylenetetrahydrofolate Reductase (NADPH) M Type Pyruvate Kinase Achromycin Panhypopituitarism, Postpartum Hypersplenism Syndrome, Wolf-Hirchhorn Vasculitis Mesylate, Doxazosin Food Stamps External Popliteal Neuropathy Clover, Water D3 Receptors, 1,25-Dihydroxyvitamin RNS3 Protein Boecks Sarcoid Platysma Muscles Butylhydroxyanisole Protein Structures, Supersecondary Hyperkalemic Periodic Paralysis, Familial Dolichoectasias, Vertebrobasilar Sodium Clavulanate Pasiviruses Nonaccidental Trauma in Children Drug Prescribings

Professional Narrative

Dr. Amber Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Harvard Med 1990
Medical Writer, Harvard Med 2010

Education

Director Medicine, Harvard Medical School 1998
Bachelor of science in nursing, Baylor College 2006

Referees


Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :